Methods of preparing non-alcohol bioactive essential oil mouth rinses
US-10434050-B2 · Oct 8, 2019 · US
Compositions and methods for treating the eye
US11878042B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11878042-B2 |
| Application number | US-202217737513-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 5, 2022 |
| Priority date | Jul 27, 2018 |
| Publication date | Jan 23, 2024 |
| Grant date | Jan 23, 2024 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to compositions comprising one or more compounds and/or extracts which induce, promote and/or improve production/release/delivery/excretion of mucin from and/or in the cornea, and methods of using the compositions to treat the eye.
First claim
Opening claim text (preview).
What is claimed is: 1. A method for producing/releasing/delivering/excreting mucin from and/or in the cornea comprising the step of administering a composition comprising: i) one or more extracts of the genus Pichia ; and ii) optionally, an ophthalmologically acceptable carrier. 2. The method according to claim 1 , wherein the extract is of a species selected from the group consisting of Pichia anomala, Pichia guilliermondii, Pichia norvegensis, Pichia ohmeri , and mixtures thereof. 3. The method according to claim 1 , wherein the extract is of Pichia anomala. 4. A method for maintaining the concentration of mucin-5AC (MUC5AC) in tears within the range of equal to or greater than 8 nanograms to 15 nanograms per milligrams of protein, comprising the step of administering a composition comprising: i) one or more extracts of the genus Pichia ; and ii) optionally, an ophthalmologically acceptable carrier. 5. A method for treating a patient having decreased or low-level production/release/delivery/excretion of mucin from and/or in the cornea comprising the step of topically administering to the eye the patient a composition comprising: i) one or more extracts of the genus Pichia ; and ii) optionally, an ophthalmologically acceptable carrier. 6. A method for promoting healing or increasing the rate of healing of wounds in and/or on the eye of a patient, comprising the step of administering compositions, comprising: i) one or more extracts of the genus Pichia ; and ii) optionally, an ophthalmologically acceptable carrier. 7. A method for improving the antimicrobial properties in tears of a patient, comprising the step of administering compositions, comprising: i) one or more extracts of the genus Pichia ; and ii) optionally, an ophthalmologically acceptable carrier.
Assignees
Inventors
Classifications
- A61K36/064Primary
Saccharomycetales, e.g. baker's yeast · CPC title
- A61K9/0048Primary
Eye, e.g. artificial tears · CPC title
Inorganic compounds · CPC title
Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers · CPC title
Carboxylic acids; Salts or anhydrides thereof · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11878042B2 cover?
- The present invention relates to compositions comprising one or more compounds and/or extracts which induce, promote and/or improve production/release/delivery/excretion of mucin from and/or in the cornea, and methods of using the compositions to treat the eye.
- Who is the assignee on this patent?
- Johnson & Johnson Surgical Vision Inc
- What technology area does this patent fall under?
- Primary CPC classification A61K36/064. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jan 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 7 related publications on this page (citations in our corpus or others sharing the same primary CPC).